Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2
Not Applicable
- Conditions
- Acute cerebral large vessel occlusion admitted within 24 hours after onset.
- Registration Number
- JPRN-UMIN000015273
- Lead Sponsor
- Department of Neurosurgery Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are considered inappropriate to participate in the study are excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method modified Rankin Scale at 90 days (+/- 10 days) after onset
- Secondary Outcome Measures
Name Time Method (1)Death within 90 days (+/- 10 day) after the onset (2)The rate of mRS score 0-2 of each affected artery (3)Symptomatic intracranial hemorrhage within 72 hours (+/- 8 hours) after onset. (4)The difference of NIHSS score between pre-treatment and at 72 hours (+/- 8 hours) after onset. (5)Other adverse events
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie endovascular salvage in acute cerebral large vessel occlusion?
How does endovascular salvage compare to standard-of-care treatments for ultra-acute cerebral embolism?
What biomarkers are associated with favorable outcomes in endovascular salvage for cerebral embolism?
What are the potential adverse events and management strategies for endovascular salvage in acute cerebral embolism?
Are there any combination approaches or competitor drugs for treating acute cerebral large vessel occlusion?